ICU Medical Inc
NASDAQ: ICUI · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
Updated 2026-04-29
ICU Medical Inc (ICUI) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for ICUI.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
ICUI historical valuation range
Where current P/E sits in ICUI's own 5Y range.
ICUI intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
ICUI valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 3848.33x
P/S Ratio — History
Current: 1.29x
Is ICUI overvalued in 2026?
ICU Medical Inc (ICUI) currently trades at $115.45 per share with a market capitalization of $2,885,371,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 47/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 3848.3x. The PEG ratio of 0.07 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Our discounted cash flow model estimates ICUI's intrinsic value at $400.23 per share, against the current market price of $115.45. This implies a margin of safety of +63.09%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: ICUI appears richly valued on our framework, with a Smart Value Score of 47/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is ICUI overvalued in 2026?
Based on a Smart Value Score of 47/100, ICUI appears overvalued. Current price exceeds what fundamentals currently justify.
What is ICUI's fair value?
Our DCF model estimates ICUI's intrinsic value at $400.23 per share, versus the current price of $115.45. This produces a margin of safety of +63.09%.
What P/E ratio does ICUI trade at?
ICUI trades at a P/E of 3848.3x on trailing twelve-month earnings.
Is ICUI a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 47/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does ICUI's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on ICUI.
What is ICUI's Smart Value Score?
ICUI's Smart Value Score is 47/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.